HITHOC for Pleural Mesothelioma: “Safe, Feasible and Effective”
A newly published study says a localized form of chemotherapy called HITHOC for pleural mesothelioma is “safe, feasible, and effective.”…
-
-
Study Reveals How TTFields and Chemotherapy Fight Mesothelioma
TTFields and chemotherapy offer one of the most potent combinations against malignant mesothelioma tumors. Now a new study reveals why… -
Asia | International | Surgery | Treatments
Pleural Mesothelioma Patients are Stronger a Year After Surgery
Pleural mesothelioma patients can be stronger and have better lung function a year after surgery than in the days and… -
Mesothelioma Update: Could New Form of Immunotherapy Help?
A new form of immunotherapy using a patient’s own cells is making headlines this month after a new study shows… -
New Studies | Prognosis | Research | Surgery | Treatments
Physical Function Predicts Mesothelioma Surgery Outcomes
A patient’s level of physical function prior to mesothelioma surgery is a strong predictor of how well they will do… -
Neoadjuvant Chemotherapy Plus Surgery for Pleural Mesothelioma: A Prospective Study
A new prospective Japanese mesothelioma study shows the potentially life-saving benefits of undergoing neoadjuvant chemotherapy followed by surgery. This has… -
Academic Medical Centers Extend Peritoneal Mesothelioma Survival
A new published study suggests that peritoneal mesothelioma patients treated at academic medical centers survive much longer than those who… -
Chemotherapy | Europe | International | Surgery | Treatments
New Study: PD Surgery and HITHOC for Pleural Mesothelioma
German doctors say a combination of extended PD surgery and HITHOC has produced some ‘remarkable’ results for patients with pleural… -
New “Real World” Study of Immunotherapy for Peritoneal Mesothelioma
A new study from one of the nation’s top cancer centers supports the role of immunotherapy in peritoneal mesothelioma treatment.… -
Comparing Second-Line Therapies for Recurrent Mesothelioma
University of Pennsylvania researchers have some hopeful news for people with recurrent mesothelioma after chemotherapy: Second-line immunotherapy might increase their…
